The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2013
Filed:
Feb. 11, 2008
Manuel DE Lera Ruiz, Branchburg, NJ (US);
Kevin D. Mccormick, Basking Ridge, NJ (US);
Christopher W. Boyce, Flemington, NJ (US);
Robert G. Aslanian, Rockaway, NJ (US);
Younong Yu, East Brunswick, NJ (US);
Pietro Mangiaracina, Monsey, NY (US);
Junying Zheng, New Providence, NJ (US);
Michael Y. Berlin, Flemington, NJ (US);
Stephanie Louise Ciesla, Morristown, NJ (US);
Chia-yu Huang, Princeton Junction, NJ (US);
BO Liang, East Brunswick, NJ (US);
Manuel de lera Ruiz, Branchburg, NJ (US);
Kevin D. McCormick, Basking Ridge, NJ (US);
Christopher W. Boyce, Flemington, NJ (US);
Robert G. Aslanian, Rockaway, NJ (US);
Younong Yu, East Brunswick, NJ (US);
Pietro Mangiaracina, Monsey, NY (US);
Junying Zheng, New Providence, NJ (US);
Michael Y. Berlin, Flemington, NJ (US);
Stephanie Louise Ciesla, Morristown, NJ (US);
Chia-Yu Huang, Princeton Junction, NJ (US);
Bo Liang, East Brunswick, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
In its many embodiments, the present invention provides a novel class of biaryl compounds as inhibitors of ÿ2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the ÿ2C adrenergic receptors using such compounds or pharmaceutical compositions.